Cargando…
Response to Cysteamine in Osteoclasts Obtained from Patients with Nephropathic Cystinosis: A Genotype/Phenotype Correlation
Bone complications of cystinosis have been recently described. The main objectives of this paper were to determine in vitro the impact of CTNS mutations and cysteamine therapy on human osteoclasts and to carry out a genotype-phenotype analysis related to osteoclastic differentiation. Human osteoclas...
Autores principales: | Quinaux, Thomas, Bertholet-Thomas, Aurélia, Servais, Aude, Boyer, Olivia, Vrillon, Isabelle, Hogan, Julien, Lemoine, Sandrine, Gaillard, Ségolène, Alioli, Candide, Vasseur, Sophie, Acquaviva, Cécile, Peyruchaud, Olivier, Machuca-Gayet, Irma, Bacchetta, Justine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467406/ https://www.ncbi.nlm.nih.gov/pubmed/34572146 http://dx.doi.org/10.3390/cells10092498 |
Ejemplares similares
-
Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy
por: Machuca-Gayet, Irma, et al.
Publicado: (2020) -
Muscle and Bone Impairment in Infantile Nephropathic Cystinosis: New Concepts
por: Haffner, Dieter, et al.
Publicado: (2022) -
Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
por: Bouazza, Naïm, et al.
Publicado: (2011) -
Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
por: Langman, Craig B.
Publicado: (2023) -
Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
por: Alioli, Candide, et al.
Publicado: (2022)